SKI Market

Indian Indices

Nifty

26,215.55 10.25
(0.04%)

Sensex

85,720.38 110.87
( 0.13%)

Bank Nifty

59,737.30 209.25
( 0.35%)

Nifty IT

37,446.30 81.70
( 0.22%)

Global Indices

Nasdaq

47,439.25 305.79
(0.65%)

Dow Jones

6,833.01 46.13
(0.68%)

Hang Seng

50,154.28 595.21
(1.20%)

Nikkei 225

9,690.34 80.81
(0.84%)

Forex

USD-INR

89.15 -0.06
(-0.06%)

EUR-INR

102.93 0.12
(0.12%)

GBP-INR

117.17 0.31
(0.26%)

JPY-INR

0.57 0.00
(0.22%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Sun Pharmaceutical Industries Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

524715

INE044A01036

99.2482659

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

SUNPHARMA

92.65

433043.97

EPS(TTM)

Face Value()

Div & Yield %

19.48

0.89

Back

GAIL (India) consolidated net profit declines 26.77% in the September 2025 quarter

Oct 31,2025

Net profit of GAIL (India) declined 26.77% to Rs 1972.40 crore in the quarter ended September 2025 as against Rs 2693.55 crore during the previous quarter ended September 2024. Sales rose 4.86% to Rs 35537.12 crore in the quarter ended September 2025 as against Rs 33888.90 crore during the previous quarter ended September 2024.

Particulars	Quarter Ended
	Sep. 2025	Sep. 2024	% Var.
Sales	35537.12	33888.90	5
OPM %	9.74	11.62	-
PBDT	3742.25	4391.63	-15
PBT	2565.39	3469.65	-26
NP	1972.40	2693.55	-27

26,215.55 10.25 (0.04%)

85,720.38 110.87 ( 0.13%)

59,737.30 209.25 ( 0.35%)

37,446.30 81.70 ( 0.22%)

47,439.25 305.79 (0.65%)

6,833.01 46.13 (0.68%)

50,154.28 595.21 (1.20%)

9,690.34 80.81 (0.84%)

89.15 -0.06 (-0.06%)

102.93 0.12 (0.12%)

117.17 0.31 (0.26%)

0.57 0.00 (0.22%)